Publisher: Frost & Sullivan
Category: In Vitro Diagnostics

In Vitro Diagnostics market research reports by Frost & Sullivan

(35 reports matching your criteria)
    • Global Next generation Diagnostics, Outlook 2023

      Global Next generation Diagnostics, Outlook 2023 As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthc ... Read More

    • PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities

      PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfoli ... Read More

    • Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025

      Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025 Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with c ... Read More

    • Global Prenatal Genetic Testing—Forecast to 2026

      Global Prenatal Genetic Testing—Forecast to 2026 New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, ... Read More

    • United States Molecular Point-of-Care Testing Growth Opportunities

      United States Molecular Point-of-Care Testing Growth Opportunities Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testi ... Read More

    • Women’s Health Solution Growth Opportunities

      Women’s Health Solution Growth Opportunities As the healthcare industry moves toward the ideas of personalized medicine and health equity, an important consideration in disease and treatment experiences is gender. While fine-tuning treatment paradigms for women will probably take decades, several ar ... Read More

    • In Vitro Diagnostic eCommerce Business Models Growth Opportunities

      In Vitro Diagnostic eCommerce Business Models Growth Opportunities Diagnostics are central to healthcare, but not accessible to all. A 2020 Lancet study states that 47% of the global population has little to no access to accurate diagnostics, emphasizing the need for equitable distribution across ge ... Read More

    • Next-generation Diagnostics Outlook, 2022

      Next-generation Diagnostics Outlook, 2022 In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosi ... Read More

    • United States Clinical Laboratory Services Growth Opportunities

      United States Clinical Laboratory Services Growth Opportunities The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9 ... Read More

    • AI Augmentation in Molecular Diagnostics

      AI Augmentation in Molecular Diagnostics This Frost & Sullivan research service discusses advances in AI integration in Molecular Diagnostics, highlights key advantages of incorporating AI in the diagnostics workflow and roadblocks that have prevented it from becoming mainstream. While AI is widely ... Read More

1 2 next >

Cookie Settings